My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Archivos Españoles de Urología (Ed. impresa)
Print version ISSN 0004-0614
Abstract
CRUZ GUERRA, Nicolás Alberto. Outcomes of maximal androgen blockade in prostate cancer patients at health area with type 2 reference hospital (1st part). Quality of life: application of the EORTIC QLQ-C30 instrument. Arch. Esp. Urol. [online]. 2009, vol.62, n.6, pp.431-459. ISSN 0004-0614.
Objectives: To analize the influence that maximal androgen blockade (MAB) exerts on quality of life in patients from the health area of Zamora diagnosed of prostate adenocarcinoma between 2000-2005. Methods: Basal, 12-month, 24-month and 36-month application of the health-related quality of life measurement instrument EORTC QLQ-PR25 to the population sample (n= 111), as well as a control sample (n= 100). We performed a comparative study of the outcomes between groups; between various time measurements in MAB patients; and inter-categories/ intervals of some variables in patients with hormonal deprivation therapy (third year of follow-up). Results: Cognitive and symptomatic fields were affected in patients with MAB at some specific time points. No field showed a significant constant worsening through the period of study for hormonally deprivated patients. A recovery is seen in the sociofamiliar field. Less academic level in MAB patients represents a distinguishing factor leading to worse outcomes in the healthrelated quality of life parameters analyzed here. Conclusions: There is a negative initial repercussion of MAB on quality of life, although tinged according to the different fields studied.
Keywords : Prostate cancer; Hormonal therapy; Quality of life.